Di Santo
Federico Di Santo, Sossano (vi) IT
| Patent application number | Description | Published |
|---|---|---|
| 20120119686 | Method for controlling a motor - A method for controlling a motor by an inverter and by a vectorial technique, comprising the following steps: determining the value of a quadrature current Iq necessary for said motor to generate the desired torque; calculating the value of a direct current to be supplied to the motor by an equation as a function of the phase of the current vector on which the torque constant of the motor depends; calculating the power current of said motor from the direct current and the quadrature current; supplying the power current to the motor through the inverter. | 05-17-2012 |
| 20150340971 | Method for synchronizing a synchronous reluctance electric machine - A method of synchronizing a synchronous reluctance electric machine wherein the machine has no speed and/or residual magnetization voltage sensor and includes power terminals and rotating masses whose mechanical rotation frequency is subjected to speed transients caused by power cut-off conditions. The method includes at least one step of applying a control voltage with predetermined amplitude and duration to the terminals after the transients, and one step of detecting the electric current induced by the control voltage, the current induced by the voltage having a harmonic spectrum variable according to the frequency differential between the frequency of the control voltage and the mechanical rotation frequency of the rotating masses, to restore power and synchronous rotation control of the machine. | 11-26-2015 |
James Di Santo, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20120094312 | BOOSTING HUMAN DENDRITIC CELL DEVELOPMENT, HOMEOSTASIS AND FUNCTION IN XENOGRAFTED IMMUNODEFICIENT MICE - The present invention relates to a transgenic animal mode system based on the development of transgenic mice bearing components of the human immune system. Specifically, the Invention relates to a Flk2 deficient Rag “γc” transgenic mouse and the engraftment of said mouse with human hematopoietic stem cells. The present invention further presides methods for increasing the numbers of functionally competent human dendritic cells is and the hematopoietic targets cells that they interact with in said transgenic mouse through the administration of Flk2L. The transgenic animal model system of the invention may be used for testing human vaccine candidates, for screening potential Immune adjuvants and for developing novel therapeutics. | 04-19-2012 |
| 20140165220 | BOOSTING HUMAN DENDRITIC CELL DEVELOPMENT, HOMEOSTASIS AND FUNCTION IN XENOGRAFTED IMMUNODEFICIENT MICE - The present invention relates to a transgenic animal model system based on the development of transgenic mice bearing components of the human immune system. Specifically, the invention relates to a Flk2 deficient Rag | 06-12-2014 |
Joe Di Santo, Blackburn North AU
| Patent application number | Description | Published |
|---|---|---|
| 20140309716 | METHOD FOR OPERATING A DIRT STOP SURFACE, DIRT STOP SURFACE UNIT AND DIRT STOP SURFACE ASSEMBLED THEREFROM - The invention provides a method of reducing an expected length of hospital stay of a patient during a recovery period after surgery, comprising repeated sessions of applying electrical stimulation (W, I) through one or more pairs of electrodes contacting a skin surface in the vicinity of the surgical site. | 10-16-2014 |
| 20160136417 | TREATING SKIN ULCERS - The invention provides the use of electrical pulses (I, W) to reduce, improve, heal or prevent recurrence of a chronic ulcer, comprising administering to a need ( | 05-19-2016 |
Joe Di Santo, Blackburn North, Victoria AU
| Patent application number | Description | Published |
|---|---|---|
| 20160136417 | TREATING SKIN ULCERS - The invention provides the use of electrical pulses (I, W) to reduce, improve, heal or prevent recurrence of a chronic ulcer, comprising administering to a need ( | 05-19-2016 |
Roberto Di Santo, Rome IT
| Patent application number | Description | Published |
|---|---|---|
| 20080255232 | Naphthyl Derivatives as Inhibitors of Beta-Amyloid Aggregation - Compounds useful in the treatment of disorders characterized by deposits of amyloid aggregates are herein described together with pharmaceutical compounds containing the same. In particular the compounds of the present invention are those having the Formula (I) as reported below, where the radicals have the meaning indicated in the description. | 10-16-2008 |
Roberto Di Santo, Roma IT
| Patent application number | Description | Published |
|---|---|---|
| 20110160201 | COMPOUND WITH SEROTONINERGIC ACTIVITY, PROCESS FOR PREPARING IT AND PHARMACEUTICAL COMPOSITION COMPRISING IT - Compound of formula (I) in which R1, R2 and R3 are defined in the following description, and the pharmaceutically acceptable acid-addition or base-addition salts thereof. The invention also relates to a process and an intermediate for preparing it, and to a pharmaceutical composition comprising it. The invention also relates to the use of a novel 2H-pyrrolo[3,4-c]quinoline compound for preparing a pharmaceutical composition that is active in the treatment of disturbances of the serotoninergic system. | 06-30-2011 |